Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medx HealthMDXHF +3.02% 14-Day RSI is 61.95 as of Jul. 31, 2026. The stock has 8 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Medx Health ranks worse than 70.21% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-31), Medx Health's 14-Day RSI is 61.95.
The industry rank for Medx Health's 14-Day RSI or its related term are showing as below:
MDXHF's 14-Day RSI is ranked worse than 70.21% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 46.005
vs MDXHF: 61.95
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Medx Health 14-Day RSI Related Terms
MDXHF vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, Medx Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Medx Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health (MDXHF) has a 14-Day RSI of 61.95 as of Jul. 31, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medx Health and its competitors. According to the industry distribution chart, Medx Health ranks #608 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 70.2%.
Is Medx Health's 14-Day RSI too high?
Medx Health's current 14-Day RSI is 61.95. The Medical Devices & Instruments industry median 14-Day RSI is 46.01. Medx Health's value of 61.95 is 34.7% above this industry median. Based on the distribution chart, Medx Health ranks #608 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Medx Health's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medx Health ranks #608 out of 866 companies for 14-Day RSI. This places Medx Health in the lower half of its industry. The industry median 14-Day RSI is 46.01. Medx Health's value of 61.95 is 34.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 46.01, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medx Health's current 14-Day RSI of 61.95 is 34.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medx Health and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 46.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medx Health's current 14-Day RSI is 61.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.04 — trading 343% above its estimated fair value. The current 14-Day RSI is 61.95 and 34.7% above the Medical Devices & Instruments industry median of 46.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Medx Health (MDXHF), the current 14-Day RSI is 61.95 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDXHF has been successfully added to your 
